James Kost

3.6k total citations · 2 hit papers
34 papers, 2.5k citations indexed

About

James Kost is a scholar working on Psychiatry and Mental health, Physiology and Infectious Diseases. According to data from OpenAlex, James Kost has authored 34 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Psychiatry and Mental health, 8 papers in Physiology and 5 papers in Infectious Diseases. Recurrent topics in James Kost's work include Alzheimer's disease research and treatments (8 papers), Migraine and Headache Studies (5 papers) and Dementia and Cognitive Impairment Research (5 papers). James Kost is often cited by papers focused on Alzheimer's disease research and treatments (8 papers), Migraine and Headache Studies (5 papers) and Dementia and Cognitive Impairment Research (5 papers). James Kost collaborates with scholars based in United States, France and Canada. James Kost's co-authors include Tiffini Voss, Pierre N. Tariot, Yuki Mukai, Bruno Vellas, Christine Furtek, Michael Egan, Paul Aisen, Jeffrey L. Cummings, Erin Mahoney and Christopher Lines and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Gastroenterology.

In The Last Decade

James Kost

33 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer’s Disease

2018 471 citations Michael Egan, James Kost et al. New England Journal of Medicine profile →
Randomized Trial of Verubecestat for Prodromal Alzheimer’s Disease

2019 380 citations Michael Egan, James Kost et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
James Kost United States	19	1.0k	811	449	387	369	34	2.5k
Christine Furtek United States	14	908 0.9×	586 0.7×	54 0.1×	251 0.6×	413 1.1×	21	2.3k
Tim West United States	25	1.0k 1.0×	396 0.5×	75 0.2×	58 0.1×	173 0.5×	63	2.4k
Magdalena Korecka United States	25	899 0.9×	1.0k 1.2×	48 0.1×	76 0.2×	155 0.4×	49	2.7k
Maria Bjerke Belgium	32	2.2k 2.2×	1.8k 2.2×	136 0.3×	89 0.2×	175 0.5×	79	4.2k
Lina Ma China	20	553 0.5×	223 0.3×	78 0.2×	51 0.1×	190 0.5×	58	1.8k
Laila Abdullah United States	34	1.0k 1.0×	596 0.7×	76 0.2×	89 0.2×	280 0.8×	90	2.9k
Alan Rembach Australia	31	1.4k 1.4×	561 0.7×	300 0.7×	29 0.1×	229 0.6×	57	2.8k
P Preziosi Italy	35	696 0.7×	147 0.2×	94 0.2×	124 0.3×	395 1.1×	232	4.0k
Rebecca Baillie United States	25	1.0k 1.0×	177 0.2×	66 0.1×	131 0.3×	120 0.3×	66	3.7k
David Cheng United States	34	1.4k 1.4×	97 0.1×	131 0.3×	114 0.3×	648 1.8×	73	4.0k

Countries citing papers authored by James Kost

Since Specialization

Citations

This map shows the geographic impact of James Kost's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Kost with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Kost more than expected).

Fields of papers citing papers by James Kost

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Kost. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Kost. The network helps show where James Kost may publish in the future.

Co-authorship network of co-authors of James Kost

This figure shows the co-authorship network connecting the top 25 collaborators of James Kost. A scholar is included among the top collaborators of James Kost based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Kost. James Kost is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Voss, Tiffini, James Kost, Christine Furtek, et al.. (2023). Progression from Prodromal Alzheimer’s Disease to Mild Alzheimer’s Disease Dementia in the Verubecestat APECS Study: Adjudicating Diagnostic Transitions. Journal of Alzheimer s Disease. 92(1). 341–348. 3 indexed citations

Sur, Cyrille, Katarzyna Adamczuk, David Scott, et al.. (2022). Evaluation of 18F-flutemetamol amyloid PET image analysis parameters on the effect of verubecestat on brain amlyoid load in Alzheimer’s disease. Molecular Imaging and Biology. 24(6). 862–873. 7 indexed citations

Myers, Gary J., Philip W. Davidson, Conrad F. Shamlaye, et al.. (2020). The Seychelles Child Development Study of methyl mercury from fish consumption: analysis of subscales from the Child Behaviour Checklist at age 107 months in the main cohort. NeuroToxicology. 81. 331–338. 1 indexed citations

Egan, Michael, Yuki Mukai, Tiffini Voss, et al.. (2019). Further analyses of the safety of verubecestat in the phase 3 EPOCH trial of mild-to-moderate Alzheimer’s disease. Alzheimer s Research & Therapy. 11(1). 68–68. 63 indexed citations

Egan, Michael, James Kost, Christopher Lines, et al.. (2019). FTS3‐01‐05: FURTHER ANALYSES OF COGNITIVE OUTCOMES IN THE APECS PHASE‐3 TRIAL OF VERUBECESTAT IN PRODROMAL AD. Alzheimer s & Dementia. 15(7S_Part_17).

Egan, Michael, James Kost, Pierre N. Tariot, et al.. (2018). Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer’s Disease. New England Journal of Medicine. 378(18). 1691–1703. 471 indexed citations breakdown →

Ho, Tony W., Andrew P. Ho, Bernard Chaitman, et al.. (2012). Randomized, Controlled Study of Telcagepant in Patients With Migraine and Coronary Artery Disease. Headache The Journal of Head and Face Pain. 52(2). 224–235. 52 indexed citations

Anderson, Matt S., William D. Hanley, Bo Jin, et al.. (2010). Effect of raltegravir on estradiol and norgestimate plasma pharmacokinetics following oral contraceptive administration in healthy women. British Journal of Clinical Pharmacology. 71(4). 616–620. 18 indexed citations

Ho, Tony W., Jes Olesen, David W. Dodick, et al.. (2010). Antimigraine Efficacy of Telcagepant Based on Patient's Historical Triptan Response. Headache The Journal of Head and Face Pain. 51(1). 64–72. 38 indexed citations

10.

Ho, Andrew P., Carl Dahlöf, Stephen D. Silberstein, et al.. (2010). Randomized, controlled trial of telcagepant over four migraine attacks. Cephalalgia. 30(12). 1443–1457. 56 indexed citations

11.

Iwamoto, Marian, William D. Hanley, Amelia S. Petry, et al.. (2009). Lack of a Clinically Important Effect of Moderate Hepatic Insufficiency and Severe Renal Insufficiency on Raltegravir Pharmacokinetics. Antimicrobial Agents and Chemotherapy. 53(5). 1747–1752. 37 indexed citations

12.

Hanley, William D., Larissa Wenning, James Kost, et al.. (2009). Effect of Tipranavir-Ritonavir on Pharmacokinetics of Raltegravir. Antimicrobial Agents and Chemotherapy. 53(7). 2752–2755. 35 indexed citations

13.

Ho, Tony W., Michel D. Ferrari, David W. Dodick, et al.. (2008). Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial. The Lancet. 372(9656). 2115–2123. 429 indexed citations

14.

Mang, Thomas S., James Kost, Maureen Sullivan, & Brian C. Wilson. (2006). Autofluorescence and Photofrin-induced fluorescence imaging and spectroscopy in an animal model of oral cancer. Photodiagnosis and Photodynamic Therapy. 3(3). 168–176. 16 indexed citations

15.

Myers, Gary J., Philip W. Davidson, Christopher Cox, et al.. (2003). Prenatal methylmercury exposure from ocean fish consumption in the Seychelles child development study. The Lancet. 361(9370). 1686–1692. 446 indexed citations

16.

Hojo, Rieko, Sander Stern, Grażyna Zaręba, et al.. (2002). Sexually dimorphic behavioral responses to prenatal dioxin exposure.. Environmental Health Perspectives. 110(3). 247–254. 43 indexed citations

17.

Eichel, Louis, Karl B. Scheidweiler, James Kost, et al.. (2001). Assessment of murine bladder permeability with fluorescein: validation with cyclophosphamide and protamine. Urology. 58(1). 113–118. 26 indexed citations

18.

Eichel, Louis, et al.. (2001). Assessment of murine bladder permeability with fluorescein: validation with cyclophosphamide and protamine. Urology. 57(6). 115–115. 1 indexed citations

19.

Mudholkar, Govind S., James Kost, & Perla Subbaiah. (2001). ROBUST TESTS FOR THE SIGNIFICANCE OF ORTHANT RESTRICTED MEAN VECTOR. Communication in Statistics- Theory and Methods. 30(8-9). 1789–1810. 3 indexed citations

20.

DaCosta, Ralph S., et al.. (1997). <title>Confocal fluorescence microscopy, microspectrofluorimetry, and modeling studies of laser-induced fluorescence endoscopy (LIFE) of human colon tissue</title>. Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE. 2975. 98–107. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact